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ABSTRACT
DEVELOPMENT OF A RAPID DIAGNOSTIC ASSAY FOR THE COLORIMETRIC
DETECTION OF BACTERIAL AND VIRAL PATHOGENS USING LOOP-MEDIATED
ISOTHERMAL AMPLIFICATION COUPLED WITH A PEPTIDE NUCLEIC ACID AND
GOLD NANOPARTICLE REPORTER SYSTEM
By
William Scott Brown
Detection of pathogenic agents remains pivotal to the control and prevention of infectious
disease. While diagnostic methods continue to break barriers, the need for accurate, sensitive, and
rapid methods persists. Current methods for pathogen detection, including culture, immunochemical,
or molecular-based techniques, are subject to significant limitations that restrict their clinical utility.
Point-of-care (POC) tests have received attention for the diagnostic screening of infectious disease,
with benefits of simplicity, affordability, and convenience. This study describes the development of a
novel loop-mediated isothermal amplification (LAMP) reaction followed by a peptide nucleic acid
(PNA) probe and gold nanoparticle (AuNP) detection system that results in a colorimetric assay. By
employing modified LAMP primers, the target-dependent, co-amplification of a novel, sequence is
generated, which serves as the target for PNA/AuNP sequence-specific detection. This investigation
verified the generation of a pathogen-dependent, novel sequence via pH-sensitive colorimetric
detection, turbidimetric detection, restriction digestion, and with a molecular beacon. The generation
of the pathogen-dependent sequence permits the complimentary binding of the PNA that is
responsible for determination of the aggregative state of the AuNPs, resulting in a visual colorimetric
detection system. Viral (human immunodeficiency virus type 1) and bacterial (Staphylococcus
aureus) models were used to establish this LAMP technique, augmented with PNA/AuNP detection,
for the potential for universal identification of any microbial nucleic acid biomarker. This
investigation is the first to report sequence-specific colorimetric detection of LAMP products with a
PNA/AuNP detection method, while being amenable to POC testing for infectious disease.
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INTRODUCTION

Detection of pathogenic agents is exceedingly important for public health and the control
and prevention of disease. Diagnostic methods for infectious disease testing have grown and the
need for accurate, rapid, and sensitive diagnostic methods remains fundamental to the control,
prevention, and treatment of infectious disease. Traditional culture methods are typically the gold
standard for pathogen identification, which involves enrichment and selective media for
pathogen isolation that allows for recovery of viable pathogen isolates and further enables
susceptibility testing against antimicrobial agents. However, these methods are a laborious
process that are excessively time-demanding (Caliendo et al., 2013). In comparison,
immunological methods exploit antigen or antibody interaction for pathogen detection.
Immunological-based methods, such as the enzyme-linked immunoassay (ELISA), can be
automated and provide high-throughput of sample processing. These diagnostic platforms can be
time consuming and have moderate to high complexity, which requires trained personnel and
advanced laboratory equipment (Kozel & Burnham-Murusich, 2017). More recently, molecular
methods, more specifically nucleic acid-based tests (NATs), such as the polymerase chain
reaction (PCR), have become an essential technology for clinical diagnostics altogether(Tanner,
Zhang, & Evans, 2015).
Point-of-care (POC) testing has received increasing attention for the diagnosis of
infectious disease. Advancement with POC testing has demonstrated the capability for specimen
collection and testing to be performed outside of clinical settings and by untrained personnel
(Caliendo et al., 2013). The World Health Organization has defined the criteria for POC tests as
affordable, sensitive, specific, user-friendly, rapid, equipment-free, and deliverable to consumers.
1

Naturally, the lack of required laboratory infrastructure and trained personnel makes POC testing
highly useful in resource limited settings. Additionally, POC tests improve the turnaround time
of diagnostic assays and provide clinically relevant information that can greatly improve patient
management and enable earlier treatment and prevention efforts. Immunochemical POC
methods, such as lateral flow immunoassays, provides a highly-desired POC approach to
detection of infectious disease. These assays are typically cost-effective, rapid, and simple,
although they tend to lack sensitivity and are prone to false-negative results. Over the last several
decades, molecular diagnostic methods have become increasingly utilized in the identification
and characterization of pathogenic agents and virulence factors. Molecular diagnostics at the
POC level are in an infancy stage, however the considerable demand for sensitive and reliable
POC methods has facilitated efforts in their development (Kozel & Burnham-Murusich, 2017).
Overall, current POC tests have many diverse limitations that restrict their diagnostic
performance. Immunochemical POC tests are notorious for inadequate limits of detection (LOD)
and poor sensitivity. In comparison, molecular methods that can be classified as POC tests are
commonly cumbersome, costly, and more time-consuming that other POC assays (Gubala,
Harris, Ricco, Tan, & Williams, 2011). In response to these limitations, this study demonstrates
the proof-of-principle for a molecular diagnostic POC assay that enables rapid, sequence-specific
colorimetric detection of nucleic acid biomarkers. A viral model (human immunodeficiency
virus type 1) and bacterial model (Staphylococcus aureus) was selected to demonstrate this novel
assay.
The human immunodeficiency virus (HIV) pandemic remains a serious world-wide
health concern. In 2016, the World Health Organization (WHO) reported 36.7 million HIV
infections and 1 million HIV-related deaths (WHO, 2017). Despite impressive advancement in
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antiretroviral therapy for control of HIV infection, many challenges persist. An estimated 30% of
HIV cases remain undiagnosed. Not only do undiagnosed individuals go untreated, they are also
at increased risk for spreading the disease as well as progression to Acquired Immunodeficiency
Syndrome (AIDS). Currently, the WHO aims to reach a 90% target goal of diagnosing HIVpositive cases (WHO, 2018). Paramount to achieving this goal is rapid and early detection of
HIV infection.
Upon initial contraction of HIV, the viral infection progresses through three stages. (1)
Stage one is characterized by acute HIV infection, in which HIV replication proceeds uninhibited
by immune response mechanisms. This stage typically persists for 2 to 4 weeks. (2) Stage two
involves a latency period, classified by an adaptive immune response, which commonly lasts
years. (3) Stage three is the most severe phase of infection, in which HIV progresses to AIDS
(CDC, n.d.). Identification of acute HIV infection can serve several important purposes;
prevention strategies can be implemented to reduce potential transmission of HIV, and early
recognition of infection can impact prognosis and treatment outcome (Pilcher et al., 2004).
Traditional HIV diagnostic methods rely on immunochemical assays that detect HIVspecific antibodies produced by an immune response, as well as detection of the p24 antigen, a
structural protein in the HIV viral capsid (Patel et al., 2010). The U.S. Center for Disease Control
and Prevention (CDC), in conjunction with the Association of Public Health Laboratories,
devised an HIV testing algorithm (Figure 1) that recommends initial combinational HIV
antigen/antibody immunoassay testing that detects HIV-1 and HIV-2 antibodies, as well as the
HIV-1 p24 antigen, and follow-up testing for positive or inconclusive results (CDC Stacks.,
2014). Although these recommended HIV screening methods are FDA-approved and are a
significant improvement on earlier HIV diagnostic assays, they lack the necessary sensitivity
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required to identify acute HIV infection prior to an immune response. There is an approximate
two-week period that follows initial HIV infection, in which an HIV-positive individual will test
negative due to low concentrations of circulating HIV-specific antigens and antibodies. As a
result, FDA-approved immunoassays, recommended for initial HIV testing, can overlook acute
infection over an approximate 10-14 day period, when only HIV RNA is present as an indicator
of HIV infection (Branson & Stekler, 2011). As such, diagnostic tests capable of identifying HIV
during this acute phase, within the 10-14 day window, are critical for surveillance and prevention
efforts. Acutely infected individuals are highly contagious (Pilcher et al., 2005) and account for
up to 20% of HIV infected persons seeking testing (Branson & Stekler, 2011).

Figure 1. Recommended laboratory HIV-1/2 testing algorithm. Copyright, 2014. CDC Stacks, Public
Health Publications.

POC tests have revolutionized HIV diagnostics because they offer convenience,
simplicity, affordability and do not require elaborate equipment. Currently, two at-home HIV
testing kits are FDA-approved. Firstly, the Home Access HIV-1 Test System is home collection
kit, where a blood sample is collected and sent in to a laboratory for analysis, with results
4

provided the next day via telephone. Secondly, the OraQuick In-Home HIV Test assesses an oral
fluid sample and provides results to the consumer in-home (CDC, 2015). While these POC
immunoassays provide rapid and convenient screening for HIV infection, they suffer the same
sensitivity limitations as they are dependent on immunochemical detection mechanisms, which
impedes early detection of HIV infection and, subsequently, the WHO’s target goals. In
comparison, nucleic acid-based tests (NATs) for HIV are the most sensitive assays and enable
earlier detection of HIV, several days after initial exposure (Fiebig, 2003). However, these
methods are cost prohibitive, technically complex, and have long turnaround times of up to 3
hours; as such they are not currently amenable for POC testing. Due to these drawbacks, the
present HIV testing algorithm recommends NATs only for supplemental or confirmatory testing
(CDC Stacks, 2014).
In comparison to HIV, the bacterial species, Staphylococcus aureus, represents another
infectious agent that is relatively common amongst the human population. Although an estimated
30% of humans are asymptomatic carriers of S. aureus, the bacteria species is known to cause
sepsis, pneumonia, endocarditis, and osteomyelitis, all of which can be serious or fatal (CDC,
2011). Moreover, S. aureus has become well-known for its ability to develop resistance to many
diverse antimicrobial agents. Methicillin-resistant S. aureus (MRSA) and Vancomycin-resistant
S. aureus (VRSA) infections have become highly prevalent within clinical settings and, as such,
rapid and accurate methods for identification of drug-resistant S. aureus are necessary for
adequate treatment and prevention of these nosocomial infection (Pourmand, Hassanzadeh,
Mashhadi, & Askari, 2014).
Various diagnostic methods are currently recommended for the identification of S.
aureus. Immunological assays for the detection of S. aureus typically offer superior performance
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characteristics relative to culture methods, although they are more procedurally complex, slow,
and costly. Culture-based methods, such as the coagulase test or the metachromatic agar
diffusion assay, remain the standard methods for routine S. aureus identification. These testing
methods have a 4 to 24-hour turnaround time and commonly produce false-negative and falsepositive results. Numerous molecular diagnostic approaches, such as real-time PCR with SYBR
green or TaqMan Probe detection methods, for S. aureus identification have been established,
which extend exceptional performance and allow for combinational detection of drug-resistant
genotypes. However, these methods require expensive equipment and reagents, and are classified
as high complexity tests, which poses a significant drawback for molecular diagnostic assays for
S. aureus detection. As a result, molecular methods are only recommended for confirmatory
testing or in cases of high suspicion of drug-resistant S. aureus infection (Brown et al., 2005).
The integration of molecular diagnostic technology into the scope of POC testing may
enhance the overall reliability, accuracy, and sensitivity of current rapid POC tests, and, in
conjunction, improve human health and prevention efforts. Isothermal amplification technology
provides a promising approach to the migration of molecular diagnostic methods into the field of
POC testing (Kozel & Burnham-Murusich, 2017).
Loop-mediated isothermal amplification (LAMP) is a well characterized technique for
nucleic acid-based detection of infectious disease (Mori & Notomi, 2009) and, in addition, the
FDA has recently approved a LAMP assay for C. difficile detection (FDA, 2011). LAMP utilizes
a unique Bst DNA polymerase, with strand displacement activity, and is capable of amplifying
DNA at a constant temperature, without multiple temperature-cycling steps required with
traditional methods, which offers additional simplicity. LAMP technology has higher specificity
for the target sequence than traditional molecular applications. Four primers are used, two inner
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(FIP and BIP) and two outer primers (F3 and B3), which recognize six independent target sites
within the template DNA (Figure 2), thereby extending higher specificity than other NATs, such
as PCR (Notomi et al., 2000). FIP primers are composed of an F1c and F2 region linked together
by a Poly-T linkage (TTTT-linker). Similarly, the BIP primers contain a B1c and B2 region and
are connected by a Poly-T linkage. These linker regions provide flexibility for intermolecular
interaction.

Figure 2. Overview of LAMP primer recognition sites within the target sequence. The FIP and
BIP forward primers are designed with a F2/B2 sequence and the F1/B1 complimentary
sequence (F1c/B1c). The outer primers F3/B3 facilitate strand displacement DNA synthesis.
Notomi et al first described the LAMP mechanism (Figure 3), with amplification
achieved in a single-step reaction. This isothermal amplification method is a robust technique
that is capable of amplifying target DNA efficiently in the presence of non-target DNA. In
addition to the high specificity and simplicity, LAMP is extremely sensitive, with a limit of
detection as low as six copies per reaction (Notomi et al., 2000). In addition, LAMP can be
7

performed with crude cellular lysates, without requiring a nucleic acid extraction step (Geojith,
Dhanasekaran, Chandran, & Kenneth, 2011).
Detection of amplification can be achieved through turbidity, pH, or fluorescence. DNA
amplification produces an insoluble magnesium pyrophosphate byproduct, which precipitates
from solution, that can be detected through real-time turbidimetric measurement (Mori &
Notomi, 2009). Similarly, hydrogen ion byproducts of amplification can be visually assessed
with the inclusion of pH indicators, such as phenol red, into the reaction (Tanner, Zhang, &
Evans, 2015). Fluorescent dyes that function as intercalating agents, such as SYBR Green I, can
also serve as visual detection of amplified products.
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Figure 3. Schematic overview of the LAMP reaction mechanism. Initially, (1) the F2 region in the FIP
hybridizes the F2c within the DNA target. Strand synthesis is initiated and Bst polymerase extends the
sequence. (2) The F3 outer primer then hybridizes to F3c; (3) F3 is extended and the FIP-extended strand is
then displaced. (4) The displaced single-stranded DNA forms a self-hybridizing loop structure, as the F1c
and F1 regions hybridize. (5) The reaction then proceeds with the BIP and B3 primers, leading to the
formation of a (6) dumbbell DNA structure. This DNA product serves as a template for exponential
amplification cycling, producing a final product composed of repeats of the target sequence, that vary in
length (Notomi et al., 2000).
9

These commonly utilized LAMP detection methods (Table 1) based on turbidity, pH, and
fluorescence offer simplicity and ease of interpretation of results. However, detection based on
turbidimetry, colorimetric indicators, and florescence intercalators involve indirect detection; as
such, these detection techniques are unable to identify nonspecific amplification and, therefore,
can result in false-positives (Liu et al, 2017).
Table 1. Common LAMP detection techniques.
Detection technique

Reagent/Source of detection

Gel electrophoresis

Agarose gel

Turbidity

Magnesium pyrophosphate precipitation

Colorimetric

Phenol red (pH indicator), Hydroxynaphthol blue (metal indicator)

Fluorescence intercalating dye

SYBR Green I, Ethidium bromide, Calcein

The lack of direct or sequence-specific detection methods of LAMP products signifies a
major disadvantage for LAMP technology. Sequence-specific detection of LAMP products has
recently been described, with the incorporation of molecular beacons into LAMP (MB-LAMP).
Molecular beacons are oligonucleotide probes that contain a hairpin-loop structure and a
fluorophore and quencher. Once bound to the target sequence, the fluorophore and quencher are
brought out of proximity and a fluorescence signal is generated (Liu et al, 2017). Although this
method provides direct detection of LAMP amplicon, this technique relies on
spectrofluorometric equipment and thereby limits feasibility for POC diagnostics.
Rapid diagnostic assays for HIV identification are desirable for patient screening,
particularly in resource-limited settings. Although HIV NATs are more sensitive than
immunological methods, high cost, lengthy time to results, required equipment, and procedural
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complexities limit the feasibility of NATs for HIV testing (Karris, 2012; Fiscus, 2007). LAMP
has been amended for RNA viral detection in multiple studies (Kurosaki, 2007; Ma, 2010), with
the addition of reverse transcriptase. Curtis et al. demonstrated the efficacy of RT-LAMP for
detection of HIV-1, with primer sets designed to amplify the conserved p24 and protease gene
regions within the HIV-1 genome. The developed assay had a sensitivity as low as 10 DNA
copies/reaction and 100 RNA copies/reaction, which corresponds to an acute infection viral load,
and demonstrates the potential for highly sensitive HIV-1 detection with RT-LAMP. Results
were generated as early as 30 minutes from whole-blood samples, without the need for a nucleic
acid extraction step (Curtis, Rudolph & Owen, 2008). However, this diagnostic assay was
dependent on advanced laboratory equipment and indirect detection of LAMP products.
Peptide nucleic acid (PNA) probes are widely used in applications that include
biotechnology, gene-targeted drug therapy, and molecular diagnostics (Ray & Norden, 2000).
PNAs are synthetic DNA analogues that replace the negatively charged deoxyribose-phosphate
backbone with a rigid, charge-neutral polyamine backbone (Figure 4). These unique properties of
PNA enable it to hybridize to the corresponding compliment with a higher specificity, and
greater affinity, than DNA probes. A single base-pair mismatch has been shown to inhibit PNADNA binding (Askaravi, Rezatofighi, Rastegarzadeh, & Shapouri, 2017).

Figure 4. Chemical structure of PNA as compared to DNA (Menchise et al., 2003).
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Nanoparticles, particularly gold nanoparticles (AuNP), have received increasing attention
for use in biosensor methods. AuNP attain unique, distance-dependent, optical properties that
undergo electrostatic interactions with dsDNA, ssDNA, RNA, and PNA. Recent studies have
shown PNA-induced aggregation of AuNP results in a colorimetric change in solution, from red
to blue. This PNA-induced AuNP aggregation can be inhibited with PNA hybridization to a
complementary DNA sequence, forming PNA-DNA complexes, which provides sufficient
charge-repulsion that is necessary for AuNP monodispersion (Su, 2009; Kanjanawarut 2009).
AuNP has been readily employed in many diverse applications, including a simple and robust
approach to colorimetric detection of viral RNA (Askaravi, Rezatofighi, Rastegarzadeh, &
Shapouri, 2017), as well as clinical assays for disease-associated genes and bacterial pathogens
(Baptista et al., 2008).
Herein, I report the development of a novel isothermal amplification reaction that
generates a target-dependent sequence followed by a PNA/AnNP colorimetric reporter system.
Using modified LAMP FIP and BIP primers, the co-amplification of a novel, target-dependent,
sequence complimentary to the PNA probe is generated. PNA, in the absence of this novel
target-dependent sequence, will freely aggregate AuNP (blue); while in the presence of this
target-dependent sequence, PNA hybridizes to this co-amplified PNA-target sequence and AuNP
remains monodispersed (red) (Figure 5). The modified LAMP FIP and BIP primers, coupled
with a PNA/AuNP detection system, provides a novel, universal approach to PNA/AuNP
sequence-specific detection of LAMP products, potentially amenable for detection of any nucleic
acid target. With this assay, a nucleic acid extraction step and advanced equipment is not
required. Using a viral (HIV-1) and bacterial (S. aureus) model, the primary objective of this
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investigation is to show proof-of-principle that this diagnostic assay has the potential to be used
for detection of both viral and bacterial pathogens.

Figure 5. Overview of the POC LAMP colorimetric detection system. A specimen sample is
added to the LAMP reaction tube. LAMP proceeds isothermally and, when complete, an aliquot
is added to a second tube containing PNA and AuNP. A) Pathogen-positive sample: Target DNA
or RNA is amplified, generating a co-amplified, target-dependent sequence. The PNA probe
binds to this target-dependent sequence and AuNP remains monodispersed (red). B) Pathogennegative sample: No amplification occurs, and no target-dependent sequence is generated for
PNA binding. PNA is therefore free to induce AuNP aggregation (blue).
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MATERIALS AND METHODS

Viral Samples
RNA from the human rhinovirus type 17 (strain 33342), isolated from infected HeLa
cells, and DNA from the human herpesvirus type 1 (strain HF), isolated from infected Vero cells,
was obtained from the American Type Culture Collection.
Bacterial DNA Extraction
Genomic DNA from various bacteria species, including Staphylococcus aureus,
Klebsiella pneumoniae, Streptococcus pyogenes, Enterococcus faecalis, and Escherichia coli,
was extracted from tryptic soy broth cultures using the QIAamp DNA Mini Kit protocol
(QIAamp) for bacteria suspension cultures. In brief, bacteria cells were pelleted via
centrifugation at 5000 x g for 10 minutes. The cell pellet was resuspended in 180 µL of Buffer
AL and vortexed vigorously. A total of 20 µL of proteinase K was added to the suspension and
the mixture was incubated at 56oC for 30 minutes for cell lysis. To the sample, 200 µL of Buffer
AL was added, pulse-vortexed, and incubated at 70oC for 10 minutes. Next, 200 µL of 100%
ethanol was added and the mixture was added to the QIAamp Mini spin column. The spin
column was centrifuged at 6000 x g for 1 minute and 500 µL of Buffer AW1 was applied to the
column and centrifuged at 6000 x g for 1 minute. To the column, 500 µL of Buffer AW2 was
added and centrifuged at 20,000 x g for 3 minutes. The spin column was placed in a 1.5 mL
microcentrifuge tube and 200 µL of Buffer AE was added to the column, incubated at room
temperature for 1 minute, and centrifuged at 6000 x g 1 minute to elute DNA. The extracted
DNA was stored at -80oC.
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Primer and Probe Design
All LAMP primers were obtained from Integrated DNA Technologies (IDT), and were
reconstituted in IDTE buffer (10mM Tris, 0.1 mM EDTA, pH 8.0). A LAMP primer set designed
to amplify a 144 bp region of the S. aureus nuc gene (GenBank accession number DQ399678.1)
was used in the study. Published HIV-1 LAMP primer sets, described by Curtis et al, specific for
the p24 and protease regions, were obtained for verification of an HIV-1 RT-LAMP assay (Table
2A). These LAMP primer sets (nuc, p24, and protease) were also designed with a modification
of the FIP and BIP, substituting the traditional poly-thymine (TTTT) linkage for a 16-mer
sequence (Figure 6A). The FIP/BIP with this 16-mer PNA-linker differ at the 5’ end to maintain
primer stability, with consideration to the Tm and ΔG, and due to the limitation of a 60 nt
sequence from IDT. Three LAMP primer sets targeting the HIV-1 integrase gene region
(GenBank accession number LC201873) were designed (Table 2B) using PrimerExplorer V5
software (Eiken Chemical Co). Additionally, PNA of various length (13-, 16-, and 17-mer) was
synthesized by Panagene Co, South Korea, and contained a lysine residue on the 5’ and 3’ ends
to improve solubility. Careful consideration for PNA design was necessary, with regards to selfcomplimentary sequence stretches and purine content. The PNA probes were reconstituted in
distilled water and were designed to target the 16-mer sequence that is complimentary to the
modified FIP and BIP linkage (Figure 6C).
A molecular beacon (Integrated DNA Technologies), used for verification of the coamplified target-dependent sequence, was designed with a 5’ 6-FAMTM fluorophore and a 3’
Dabcyl quencher (Table 3), and was reconstituted in IDTE buffer (10mM Tris, 0.1 mM EDTA,
pH 8.0). This molecular beacon was designed with a 16-mer hairpin probe sequence that was
designed to hybridize the complimentary sequence of the PNA-linker (i.e. the co-amplified
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sequence described in Figure 6C). The 7-mer stem structure, with a Tm of 72.1oC, was designed
to be guanine and cytosine rich, in order to extend a Tm greater than the temperature of the
LAMP reaction (65oC). This was necessary to maintain the molecular beacon’s native state
during the isothermal reaction, and unfolded conformation only upon hybridization to the target
sequence.

B

A

C
PNA-linker connecting the F1c to the F2 (FIP)

Co-amplified, novel sequence that is
complimentary to PNA probes

Figure 6. Schematic comparison of the traditional LAMP FIP with the modified LAMP FIP design. A) The
modified 16-mer linker sequence that, when amplification proceeds, facilitates the incorporation of a targetdependent sequence that serves as the complimentary sequence to the PNA probe. This same modification is
made with the BIP primer (not shown). This allows for the tagging of LAMP amplicon for PNA probe and
AuNP colorimetric detection. B) In comparison to the traditional LAMP FIP, which contains a poly-thymine
(Poly T) linker. C) Partial structure of LAMP amplicon depicting the incorporation of the PNA-linker
sequence and the novel sequence that is co-amplified and is targeted with PNA probes.
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Table 2A. Primer sequences.
Target

S. aureus nuc

Primer name

Sequence (5’ to 3’) with linker sequences denoted in lowercase

Tm (oC)

F3

GCATTTACGAAAAAAATGGTAGA

50.0

B3

TGTTCATGTGTATTGTTAGGTT

50.0

FIP (Poly-T)

63.4

F3

GCCACGTCCATATTTATCAGTTCTttttAAATGCAAAGAAAATTGAAGTCG
TATGCTGATGGAAAAATGGTAAACGttttTAAACATAAGCAACTTTAGCCAAG
ACGTCCATATTTATCAGTTCTgtcgtcatgcttatggAAATGCAAAGAAAATTGAAGTCG
TGATGGAAAAATGGTAAACGgtcgtcatgcttatggTAAACATAAGCAACTTTAGCCAAG
ATTATCAGAAGGAGCCACC

B3

CATCCTATTTGTTCCTGAAGG

50.8

FIP (PolyT-linker)

64.9

Loop F

CAGCTTCCTCATTGATGGTTTCTTTTTAACACCATGCTAAACACAGT
TGTTGCACCAGGCCAGATAATTTTGTACTGGTAGTTCCTGCTATG
CAGCTTCCTCATTGATGGTTTCgtcgtcatgcttatggTAACACCATGCTAAACACAGT
TGTTGCACCAGGCCAGATAAgtcgtcatgcttatggGTACTGGTAGTTCCTGCTATG
TTTAACATTTGCATGGCTGCTTGAT

Loop R

GAGATCCAAGGGGAAGTGA

53.6

F3

AAAGATAGGGGGGCAACT

53.3

B3

GTTGACAGGTGTAGGTCCTA

53.3

FIP (PolyT-linker)

64.7

Loop F

GGTTTCCATCTTCCTGGCAAATTttttCTCTATTAGATACAGGAGCAGA
TGATAGGGGGAATTGGAGGTTTttttCCTATAGCTTTATGTCCACAGA
GTTTCCATCTTCCTGGCAAATTgtcgtcatgcttatggCTCTAT
TAGATACAGGAGCAGA
TGATAGGGGGAATTGGAGGTgtcgtcatgcttatggTTCCTATAG
CTTTATGTCCACAGA
TATTTCTTCTAATACTGTATC

Loop R

TATCAAAGTAAGACAGTA

41.0

BIP (Poly-T)
FIP (PNA-linker)
BIP (PNA-linker)

HIV-1 p24
(Curtis et al,
2008)

BIP (PolyT-linker)
FIP (PNA-linker)
BIP (PNA-linker)

HIV-1
protease
(Curtis et al,
2008)

BIP (PolyT-linker)
FIP (PNA-linker)
BIP (PNA-linker)
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64.0
66.3
67.1
51.5

66.3
68.7
69.8
56.3

65.3
68.1
68.9
43.7

Table 2B. Designed integrase primer sets.
Target

Primer

Primer name

Sequence (5’ to 3’) with linker sequence denoted in lowercase

Tm (oC)

FIP

68.8

F3

GCCTGATCTCTTACCTGTCCTATAAttttCCCTACAATCCCCAAAGTC
TAAGACAGCAGTACAAATGGCAGttttTCTTTCCCCTGCACTGTA
TCAAGCAGGAATTTGGAATT

B3

ATGTCTGTTGCTATTATGTCTAC

55.6

FIP

65.4

F3

TGTCCCTGTAATAAACCCGAAAATTttttACATAATAGCAACAGACATACAAAC
AAGGACCAGCAAAGCTCCTCttttTGGCACTACTTTTATGTCACT
GTACAGTGCAGGGGAAAG

B3

CCTAATGATCTTTGCTTTTCTTCT

57.07

FIP

66.1

F3

ATTACTACTGCCCCTTCACCTTttttAGAAATCCACTTTGGAAAGGA
AGTGACATAAAAGTAGTGCCAAGAAttttTCATCACCTGCCATCTGT
GGGTTTATTACAGGGACAGC

B3

TGTCTACTTGCCACACAA

55.22

FIP (PNA-linker)

ATTACTACTGCCCCTTCACCTTgtcgtcatgcttatggAGA71.6
AATCCACTTTGGAAAGGA
AGTGACATAAAAGTAGTGCCAAGAAgtcgtcatgcttatggTCAT- 71.1
CACCTGCCATCTGT

set

BIP
#1

HIV-1
Integrase

BIP
#2

BIP
#3

BIP (PNA-linker)

67.3
55.06

67.3
56.46

66.3
57.43

Table 3. Probe sequences.
Probe

Sequence (5’ to 3’)

Tm (oC)

Molecular beacon

6-FAMTM-ACCCGGCGTCGTCATGCTTATGGGCCGGGT-Dabcyl

72.1

13-mer PNA

TCGTCATGCTTAT

61.1

16-mer PNA

GTCGTCATGCTTATGG

72.2

17-mer PNA

GTCGTCATGCTTATGGG

76.0
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Preparation of pBKBH10S Plasmid Containing the HIV-1 Sequence
Plasmid pBKBH10S (Figure 7) was supplied through the NIH AIDS Research and
Reference Reagent Program. This pBluescript II-KS(+) plasmid (2961 bp) contains an 8932 bp
fragment (nt 222-9154 of the HIV-1 genome) inserted into the SstI site. This fragment contains
the complete HIV-1 proviral genome but lacks the 5’ HIV-1 long terminal repeat (LTR) region;
the lack of the LTR region allows for transcription of a noninfectious viral RNA.

Figure 7. pBKBH10S plasmid map.

The pBKBH10S plasmid vector, containing the HIV-1 fragment, and pUC19 (Lucigen) positive
control were transformed into competent E. coli cells (JM109) using standard transformation
methods. Breifly, 1 µL of plasmid vector, 50 ng of pBKBH10S and 10 pg of pUC19, was added
to 50 µL of JM109 competent cells in prechilled microcentrifuge tubes and incubated on ice for
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10 minutes. The cells were heat-shocked for 45 seconds at 42oC and placed on ice for 2 minutes.
Next, 450 µL of tryptic soy broth (TSB) was added to the cells and incubated at 37oC for 60
minutes. For blue-white color selection of transformants, 20 µL of 40 mg/mL X-gal and 100 µL
of 0.1 M IPTG was spread onto LB-ampicillin plates (Quality Biological) and allowed to absorb
into the medium for 30 minutes at room temperature. 10 µL, 100 µL, and 400 µL of each
transformation mixture was plated on the prepared LB-ampicillin plates. The plates were
incubated at 30oC for 24 hours, to reduce potential deletions in the HIV-1 fragment that can
occur at higher incubation temperatures (Joshi, 1993). After 24 incubation, single white colonies
containing the pBKBH10S plasmid were isolated and each placed in 5 mL of TSB containing 50
ug/mL ampicillin. The broth cultures were incubated overnight at 37oC with shaking at 200
RPM. Following overnight incubation, the broth cultures were re-streaked onto LB-ampicillin
plates and incubated at 30oC for 24 hours. The remainder of the broth cultures were spun down at
4000 RPM at 4oC for 15 minutes and the plasmid DNA was extracted using the Plasmid MiniPrep Kit (Empirical Bioscience). Isolated plasmid DNA was quantified and stored at -80oC.
From the re-streaked LB-ampicillin plates, single colonies were selected and cultured in TSBampicillin overnight at 37oC. The broth cultures were pelleted at 4000 RPM for 15 minutes at
4oC and cryopreserved in 50% glycerol stocks.

HIV-1 In Vitro RNA Transcription
The HIV-1 fragment insert is downstream of the T7 promoter and, therefore, it was
necessary to linearize the plasmid template so that only the HIV-1 proviral sequence is
transcribed. pBKBH10S plasmid DNA was digested with BamH I following the protocol for
Optimizing Restriction Endonuclease Reactions (New England Biolabs). The restriction digest
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reaction was terminated with the addition of 0.25 µg/µL of proteinase K and a 30 minute
incubation at 37oC. The linearized plasmid template was analyzed on a 0.8% agarose gel and
purified using the QIAamp DNA Mini Kit protocol for Cleanup of Genomic DNA.
Surfaces were decontaminated of RNases using RNase Away (Thermo Scientific). The
RNAMaxx High Yield Transcription Kit (Agilent Technologies) was used for the in vitro RNA
transcription of the HIV-1 proviral genome to produce non-infectious HIV-1 RNA. The 25 µL
transcription reaction was incubated at 37oC for 2 hours, followed by the addition of 10 U of
DNase I, incubated for 30 minutes at 37oC, to degrade plasmid DNA. The RNA transcript was
purified using the Absolutely RNA Miniprep Kit (Agilent Technologies) following the
manufacturers protocol for Purifying RNA Following and Enzymatic Reaction. The isolated
RNA product was quantified, aliquoted, and stored at -80oC.

Colorimetric LAMP Reaction
Colorimetric LAMP methods utilized the WarmStart Colorimetric LAMP 2X Master Mix
(New England BioLabs), and an in-house (home-brew) colorimetric LAMP buffer with a
composition of 10 mM KCl, 10 mM (NH4)SO4, 0.1% Tween 20, 8 mM MgSO4, 100 µM phenol
red, and adjusted to pH 8.8 with KOH. Phenol red was used in the colorimetric LAMP reactions
for the visual detection of hydrogen ions produced as a byproduct of DNA synthesis. A positive
reaction is defined as a colorimetric change from pink to yellow. The home-brew colorimetric
LAMP reaction also included 1.4 mM Deoxynucleotide (dNTP) mix, 1 mM of betaine, and 0.32
U of Bst DNA polymerase large fragment (New England BioLabs). All colorimetric LAMP
methods utilized primer concentrations of 1.6 µM FIP, 1.6 µM BIP, 0.2 µM F3, and 0.2 µM B3.
LAMP reactions were performed in a 25 µL reaction volume and were conducted in 0.2 mL PCR
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tube, at 65oC for 60 minutes (unless stated otherwise), followed by heat inactivation at 80oC for 5
minutes. For all S. aureus nuc LAMP assays, 3 µL of template DNA (10 to 30 ng) was added.
Similarly, for all HIV-1 RT-LAMP reactions, 3 µL of template RNA was added (1 to 10 ng).
Reaction mixtures were covered with 15 µL of mineral oil to prevent evaporation and potential
cross-contamination.

Real-Time Turbidimetry of LAMP
Real-time turbidity detection of the LAMP reaction involves the evaluation of a turbidity
change that occurs from magnesium pyrophosphate produced as a result of DNA amplification.
The real-time turbidimetry of the LAMP reaction was performed using the LoopAmp RealTime
Turbidimeter LA-500 (Eiken Chemical Co.), with absorbance data at 650 nm collected over 6
second intervals. Each 25 µL LAMP reaction contained 10 mM KCl, 10 mM (NH4)SO4, 0.1%
Tween 20, 8 mM MgSO4, pH adjusted to 8.8 with KOH, 1.4 mM Deoxynucleotide (dNTP) mix,
1 mM of betaine, and 0.32 U of Bst DNA polymerase large fragment. Primer concentrations
included 1.6 µM FIP and BIP, and 0.2 µM F3 and B3. For HIV-1 RT-LAMP assays, 7.5 U of
RTx Reverse Transcriptase (New England BioLabs) and 0.8 µM loop F and loop B primers was
incorporated into the reaction. The reaction was carried out at 65oC for 60 minutes (unless
otherwise stated), and then 80oC for 5 minutes for heat inactivation. For turbidity of LAMP
product detection, the threshold time (Tt min) is reported once the turbidity moving average
differentiation exceeds the threshold.
Sequence Verification of the Target-Dependent Co-amplified PNA-Linker Sequence
Two approaches were used to confirm the co-amplification of the PNA-linker sequence:
1) Restriction digestion and 2) Molecular beacon probe. With target-dependent LAMP
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amplification, the linker sequence within the FIP and BIP primers are co-amplified with the
target sequence. As a result, target-dependent LAMP amplification generates the target site for
PNA probe hybridization.
To confirm the generation of the PNA hybridization site, a restriction digest of S. aureus
nuc LAMP amplicon and the HIV-1 protease amplicon was performed using Msl I and was
resolved on a 4% agarose gel. Each 4% agarose gel electrophoresis run included a 50 bp
molecular marker (Promega) and was run for 1-2 hours followed by UV transillumination. For
each of the two LAMP amplicon products (S. aureus nuc and HIV-1 protease), a Msl I restriction
site was only located within the PNA-linker sequence.
Additionally, a molecular beacon LAMP (MB-LAMP) assay was conducted for
sequence-specific detection of LAMP amplicon containing the target-dependent PNA
complimentary sequence. Fluorescent detection of the target sequence, during the LAMP
reaction, was performed with a molecular beacon concentration of 0.32 µM, adopted from Liu, et
al. (2017), and was monitored in real-time using a LightCycler 96 (Roche Life Science). MBLAMP amplification was performed under 90 cycles at a constant temperature for 60 seconds
(one cycle), with fluorescence measured in 30 second intervals. All molecular beacon reaction
mixtures were performed in a 25 µL reaction tube that contained 20mM Tris-HCl, 10 mM
(NH4)2SO4, 50 mM KCl, 8 mM MgSO4, 0.1% Tween 20, and pH 8.8, 1.4 mM dNTPs, 8 U of Bst
2.0 DNA Polymerase (New England BioLabs), 1.6 µM FIP and BIP, and 0.2 µM F3 and B3;
HIV-1 reverse transcription MB-LAMP assays included 0.8 µM loop F and loop B primers, as
well as 7.5 U of RTx Reverse Transcriptase (New England BioLabs). Temperature conditions for
the MB-LAMP reaction were determined experimentally by testing a temperature range of 58oC
to 72oC.
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PNA/AuNP Colorimetric Detection
For the development and of the PNA and AuNP colorimetric detection of LAMP
amplicon, PNA of various lengths (13-, 16-, 17-, and 20-mer) were selected (sequences
described in Table 3). The PNA serves two functions in this colorimetric assay: 1) sequencespecific probe hybridization of the target and 2) unbound PNA promotes aggregation of the
AuNP. Citrate-coated BioPure AuNP (NanoComposix) of various sizes (5 nm, 10 nm, 15 nm,
and 30 nm) were chosen for investigation in this novel detection system of LAMP products.
AuNP was evaluated at concentrations that provided sufficient visual color indication of AuNP
monodispersion (red) and aggregation (blue) states. The AuNP colorimetric detection of PNADNA complexes was explored over variable conditions, including temperature, incubation time,
buffer conditions, and LAMP amplicon input.

Colorimetric detection of LAMP amplicon with PNA probes was achieved with a twostep hybridization and detection procedure. A 10 µL preincubation mixture containing 0.3 µM of
PNA (17-mer), 0.2X Phosphate Buffer Saline (2 mM phosphate, 27.4 mM NaCl, and 0.54 mM
KCl, at pH 7.4) and 1 µL of LAMP DNA amplicon was heated at 95oC for 5 minutes for
complete DNA denaturation. The DNA-PNA preincubation mixture was snap-cooled on ice for 2
minutes, to preserve the single stranded DNA. The mixture was allowed to reach room
temperature over a 5-minute period, to allow PNA probe hybridization. Lastly, 10 µL of 30 nm
size AuNP was added, for a final volume of 20 µL that contained 1 nM of AuNP. The
colorimetric results were visualized after 1 minute. For detection of HIV-1 RT-LAMP products,
an increase in PNA (1.5 µM) was utilized in the two-step hybridization and detection procedure.
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RESULTS

S. aureus nuc Colorimetric LAMP
With the home-brew colorimetric LAMP reaction utilizing phenol red indicator, a
positive result was defined as a color change from pink to orange/yellow. The nuc region of S.
aureus was targeted for the LAMP reactions because this gene is highly conserved within the S.
aureus species. For the S. aureus nuc LAMP reactions, 3 µL of template DNA (3.3x106 to
1.0x107 copies) was used with the poly-T-linker and PNA-linker primers. Initially, with the inhouse colorimetric buffer and bst DNA polymerase large fragment, run at 65oC for 60 minutes, a
color change was observed from pink to yellow for both the (1) polyT-linker and (2) PNA-linker
primer sets (Figure 8). This indicated the successful amplification of the target region with the
PNA-linker sequence FIP and BIP primers, suggesting the feasibility for the incorporation and
co-amplification of a novel 16-mer sequence (Figure 6C) that is complimentary to the PNA
probes.

1

2

Negative
control

S. aureus
DNA

Figure 8. Modified PNA-linker primers
successfully amplified the nuc target; (1) polyTlinker FIP/BIP and (2) PNA-linker FIP/BIP.
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To further support the initial findings that the modified FIP and BIP primers can successfully
amplify a target region, the S. aureus nuc LAMP was performed using the WarmStart
Colorimetric LAMP 2X Master Mix (New England BioLabs). After 60 minutes, an evident color
change was observed (from pink to yellow) with both the Poly-T-linker and the PNA-linker FIP
and BIP primers (Figure 9). For each of these colorimetric LAMP reactions, the results indicate
that amplification of the nuc region proceeded effectively, based on a reduction in the pH of the
reaction mixture, with the modified FIP/BIP linkage.

1

2

S. aureus
DNA

Negative
control

Figure 9. nuc LAMP with modified FIP/BIP primers
was successful with a commercial LAMP kit; (1)
polyT-linker FIP/BIP and (2) PNA-linker FIP/BIP.

Modified primer specificity at the 65oC reaction temperature was evaluated with numerous
bacterial species’ DNA controls, to ensure the modified (PNA-linker) nuc LAMP FIP and BIP
primers remained equivalently specific to the S. aureus nuc target region, in comparison to the
poly-T-linker FIP and BIP primers (Figure 10). It was noted that the time for a positive result
(color change from pink to yellow) was approximately 15 minutes slower, relative to the poly-Tlinker primer set.
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Figure 10. Assessment of modified FIP/BIP primer specificity.

S. aureus Turbidimetric LAMP
Since the modified FIP and BIP primers, for both S. aureus and HIV-1, were successful
(calorimetrically) in amplification of the corresponding target regions, we sought to further
support this novel LAMP technique with an alternative detection method. Run in triplicate with
turbidimetric detection, the S. aureus nuc LAMP assay yielded positive amplification, as
described in methods, with the modified FIP/BIP primers (Table 4). It was noted that the LAMP
reaction using the PNA-linker FIP and BIP amplified approximately 15 minutes slower than the
poly-T-linker counterpart, with equivalent DNA template input (30 ng).
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Table 4. nuc LAMP with Turbidimetry Detection
Component

Average Tt with Standard
Deviation (min:sec)

Poly-T-linker FIP/BIP

Threshold Time Tt
(min:sec)
36:54

Df Value

Poly-T-linker FIP/BIP

34:42

36:00 (+/-) 1.15

Poly-T-linker FIP/BIP

36:24

0.247

PNA-linker FIP/BIP

40:00

0.258

PNA-linker FIP/BIP

39:36

PNA-linker FIP/BIP

44:48

0.245

41:30 (+/-) 2.89

0.260

0.253
0.256

E. faecali negative control

_

_

0.00

E. coli negative control

_

_

0.00

The modified PNA-linker FIP and BIP primers, that promote the incorporation of the
complimentary sequence for PNA and AuNP colorimetric detection, results in two PNA binding
sites within each amplicon; one site via the FIP-linker and a second site from the BIP-linker. To
determine if a single PNA binding site (i.e. PNA-linker FIP and Poly-T-linker BIP) within each
amplicon product was sufficient for PNA/AuNP detection, the nuc LAMP assay was conducted
with combinations of FIP and BIP linkers (Table 5). Interestingly, it was observed that a
combination of PNA-linker FIP and poly-T-linker BIP yielded turbidimetric-positive results
faster than any other FIP/BIP linker combination. These results were reproduced and a similar
turbidimetric data set was observed.
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Table 5. Primer linkage combinations with the nuc LAMP assay.
Component

Poly-T-linker FIP and BIP

Threshold Time
Tt (min:sec)

Average Tt with
Standard Deviation
(min:sec)

29:30

Df Value

0.245
29:27 (+/-) 0.07

Poly-T-linker FIP and BIP

29:24

PNA-linker FIP and BIP

35:54

0.245
0.259
35:57 (+/-) 0.07

PNA-linker FIP and BIP

36:00

PNA-linker FIP and Poly-T-linker BIP

25:24

0.261
0.249
25.5 (+/-) 0.14

PNA-linker FIP and Poly-T-linker BIP

25:36

0.257

Poly-T-linker FIP and PNA-linker BIP 42:06

0.243
42.5 (+/-) 0.57

Poly-T-linker FIP and PNA-linker BIP 42:54

0.240

Sequence Verification of the Co-amplified PNA-Linker Sequence within the nuc Amplicon
With the successful amplification of bacterial (S. aureus) nuc target using the modified
FIP and BIP primers, it was necessary to verify the generation of the PNA-linker sequence
within the LAMP product. To accomplish this, an Msl I digest (restriction sites only located
within the FIP/BIP PNA-linker) of the S. aureus nuc amplicon was analyzed via gel
electrophoresis on a 4% agarose gel. The results were promising, indicating several important
elements: 1) The amplicon produced using the poly-T-linker FIP/BIP, when subjected to the
restriction digestion, did not digest. 2) However, the amplicon produced with the PNA-linker
FIP/BIP was successfully digested. Additionally, comparing the polyT-linker amplicon to the
PNA-linker amplicon [undigested], a difference in banding pattern can be observed based on the
LAMP product concatemer size difference associated with the 16-mer PNA-linker versus the
four thymine polyT-linker. (Figure 11). This demonstrated that the modified FIP/BIP nuc LAMP
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product does incorporate the PNA-linker sequence into the amplicon and, by extension, the novel
target sequence for the PNA probes.

Figure 11. Restriction digestion of the S. aureus nuc LAMP. This provides verification
of the PNA-linker co-amplified with the nuc amplicon.

Sequence-specific verification of the co-amplification of the PNA-linker sequence was
further investigated using a molecular beacon probe. MB-LAMP was conducted initially with the
S. aureus nuc target. The molecular beacon was designed to hybridize the 16-mer, novel
sequence that is complimentary to PNA probes. Because the Poly-T-linker nuc LAMP amplicon
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lacks this sequence, it was included as a negative control. Run in triplicate at 60oC, the molecular
beacon was successful in detection of the complimentary PNA-linker LAMP product, however
the poly-T-linker nuc LAMP amplicon also produced a fluorescent signal (Figure 12). In
addition, H2O negative controls were run with each primer set (PNA-linker and PolyT-linker);
all negative controls displayed atypical fluorescent curves. These atypical curves occurred for all
negative controls run.
Identical, late cycle, atypical curve with negative controls also occurred with the study
(Liu et al., 2017) that previously described the MB-LAMP technique. They attributed this
phenomenon to primer dimerization and alleviated the nonspecific detection by increasing the
temperature. However, with a temperature increase utilizing our molecular beacon, the PolyTlinker amplicon was still detected up to 68oC (Figure 13). Any temperatures explored beyond
this resulted in no fluorescent detection, potentially due to the molecular beacon melting off it’s
16-mer target sequence or at these higher temperatures, the LAMP reaction was inhibited.

PNA-linker nuc amplicon
Poly-T-linker nuc amplicon
Negative control

Figure 12. Initial MB-LAMP detection of amplicon containing the PNA-linker.
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PNA-linker nuc amplicon

Poly-T-linker nuc amplicon

Figure 13. MB-LAMP at higher temperatures continued to indicate nonspecific fluorescence
associated with the Poly-T-linker amplicon.

PNA and AuNP Colorimetric Detection of nuc Amplicon
Initially, AuNP of 15 nm size was selected for investigation in the development of this
PNA/AuNP detection system. This size AuNP was selected for initial testing based on much of
the published literature utilizing AuNP for nucleic acid detection. AuNP (15 nm) at a
concentration of 3.3 nM was selected, as it presented an optically visible (red) color indication of
AuNP in the monodispersed state. In addition, a 16-mer PNA was selected and added to the
AuNP at a concentration of 0.5 µM for the verification of PNA-induced aggregation of AuNP
(Figure 14). The PNA concentrations were titrated with the 3.3 nM AuNP to determine the
minimal PNA concentration that induced AuNP aggregation (blue). Sufficient gold nanoparticle
aggregation was achieved with 0.2 µM PNA (16-mer).
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1

2

Figure 14. Verification of PNA-induced aggregation of AuNP. 1) AuNP producing an optically
visible color indication of monodispersion and 2) immediate aggregation of AuNP with the
addition of 0.5 µM PNA.

Because the LAMP product input into the PNA/AuNP detection assay contains a number
of potentially interfering compounds, the individual components involved in the LAMP reaction
were added to the AuNP (15 nm) to determine if these components induce AuNP aggregation.
LAMP reagents were tested with the AuNP at the same concentrations utilized in the LAMP
reaction (see methods). Deoxynucleotide triphosphate mix (dNTPs), primer mix, betaine, homebrew buffer, isothermal amplification buffer (bst 2.0), and isothermal amplification buffer II (bst
3.0) were tested individually with AuNP. All components did not promote AuNP aggregation,
except the bst 3.0 buffer (New England BioLabs). This indicated that bst 3.0 may not be feasible
for use with the 15 nm size AuNP. This was attributed to the higher KCl concentration (150 mM)
in the isothermal amplification buffer II, as ionic salts have been repeatedly described to promote
AuNP aggregation. For the 15 nm AuNP (3.3 nM), 20 mM KCl promoted aggregation of AuNP.
The PNA/AuNP assay was explored with nuc LAMP amplicon, involving a preincubation step adopted from Su et al., (2009). This involved the pre-annealing of 0.2 µM PNA
(16-mer) to LAMP DNA with the use of a PBS hybridization buffer, followed by the addition of
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AuNP and heating of the mixture to 90oC to denature the target DNA and facilitate PNA probe
binding. This approach provided slight discrimination between a positive and negative LAMP
amplicon (Figure 15); with (A) PNA-DNA complexes (PNA bound to the compliment sequence)
stabilizing AuNP against aggregation (red) and, with (B) the amplicon that lacks the coamplified PNA complimentary sequence, PNA freely induced AuNP coagulation (blue).

Figure 15. PNA/AuNP detection of LAMP amplicon; (A)
PNA-linker amplicon and (B) polyT-linker amplicon.

PNA and AuNP sequence-specific detection of LAMP products has not been previously
described, so these initial results were encouraging. However, it was necessary to improve the
visual color detection for a positive/negative result. This pre-incubation procedure was explored
over extended incubation time and temperatures (2 to 30 mins; 60oC to 90oC). Extended
PNA/DNA pre-incubation time and temperature demonstrated no effect on visual colorimetric
detection, and no significant improvement in the detection assay was observed (Figure 16).
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PolyT

Figure 16. PNA/AuNP detection assay did not improve at different temperatures.

Since the PNA/AuNP detection assay was not significantly improved over temperature or
incubation time variables, additional PNA sizes (13-mer and 17-mer) were obtained for
investigation in the PNA/AuNP colorimetric detection system. In addition to the 15 nm AuNP
size, AuNP of 5 nm, 10 nm, and 30 nm were obtained to evaluate this sequence-specific
detection method. It was previously observed (with 15 nm AuNP) that with higher
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concentrations of AuNP, higher PNA concentrations were required to promote AuNP
aggregation. Therefore, with each AuNP size, diluted concentration that produced optically
sufficient visual color of the monodispersed state (red) were selected. For each PNA (13-, 16-,
and 17-mer) the AuNP-aggregative potential was compared with each of the AuNP sizes: 5 nm
(Figure 17), 10 nm (Figure 18), 15 nm (Figure 19), and 30 nm (Figure 20).
These results showed that the smaller 5 nm AuNP was extensively resistant to
aggregation with all PNA lengths. Furthermore, across all AuNP sizes, the 13-mer PNA was the
least successful in inducing AuNP aggregation, with 100-fold more (relative to the 16-mer PNA)
required to visualize AuNP aggregation. In comparison, the 17-mer PNA produced the best
aggregation results throughout all AuNP size experiments and the largest, 30 nm, AuNP was the
most sensitive to PNA.

5 nm AuNP (100 nM)

Figure 17. PNAs (variable concentration) ability
to induce aggregation of 5 nm size AuNP.
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10 nm AuNP (10 nM)

Figure 18. PNAs (variable concentration) ability
to induce aggregation of 10 nm size AuNP.

15 nm AuNP (3.3 nM)

Figure 19. PNAs (variable concentration) ability
to induce aggregation of 15 nm size AuNP.
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30 nm AuNP (1.0 nM)

Figure 20. PNAs (variable concentration) ability
to induce aggregation of 30 nm size AuNP.

Considering these results, it would appear that PNA-induced aggregation of AuNP increases as
the AuNP size increases (Figure 21) and as a function of PNA size (Figure 22). Based on these
inclinations, the 17-mer PNA and 30 nm AuNP was chosen for the continued development of the
PNA/AuNP colorimetric detection assay.
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Figure 21. PNA aggregates larger AuNP more efficiently.

Figure 22. Longer PNA aggregates AuNP more efficiently.

The 17-mer PNA and 30 nm AuNP did not translate over to the previously described
PNA/AuNP colorimetric assay, due to the improved aggregative potential of the larger AuNP
and PNA. The addition of a rapid-cooling on ice step, after the initial denaturation of LAMP
DNA, significantly improved the PNA/AuNP colorimetric detection of nuc LAMP products
(Figure 23). It should be noted that the 17-mer PNA, when bound to the 16-mer target sequence,
has a single-base 3’ overhang that may have an impact on the AuNP aggregation. This sequence39

specific colorimetric detection was further visualized on filter paper (Figure 24). It was observed
that the positive (red) and negative (blue) color indication of results faded after 10-20 minutes;
aggregated 30 nm AuNP progressively precipitates from solution over this time-period.
Although, resolving these colorimetric results on filter paper was noted to extend the
positive/negative results by upwards of 90 minutes. In addition, nuc amplicon containing only a
single PNA binding site per amplicon (i.e. PNA-linker FIP and PolyT-linker BIP), described in
Table 5, was unable to discriminate a positive and negative result. This suggests that, with this
PNA/AuNP assay, the use of both FIP and BIP with the PNA-linker is required.

PNA-linker

PolyT-linker

PNA-linker PolyT-linker

Figure 23. PNA/AuNP sequence-specific
detection of nuc LAMP amplicon.

Figure 24. PNA/AuNP detection of nuc LAMP
DNA and extrapolated on filter paper.
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Confirmation of pBKBH10S Plasmid
Bacterial transformation using the pBKBH10S plasmid vector was verified through a
restriction digest with BamH I (Figure 25), with only one BamH I restriction site that present in
the plasmid that exists outside of the HIV-1 proviral insert.

11.9 kb
Figure 25. pBKBH10S plasmid with
BamH I restriction site.

Banding patterns were observed, comparing digested pBKBH10S plasmid to undigested plasmid.
A 1 kb ladder (Promega) was run, along with the digested material, on a 0.8% agarose gel for 2
hours at 100 V. The digested, linearized plasmid yielded a different banding pattern than the
circular plasmid, as a result of different migration rates (Figure 26). The pronounced band for the
digested plasmid DNA (lanes 1, 3, and 5) was observed above the 10 kb molecular marker,
indicative of the 11.9 kb size plasmid.
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Figure 26. Verification of pBKBH10S plasmid transformation and isolation.

The linearized plasmid was subjected to RNA transcription, using T7 RNA polymerase,
to transcribe the HIV-1 insert region of the pBKBH10S plasmid. Following RNA transcription,
DNase I was added to the mixture to degrade the plasmid DNA template before conducting RNA
isolation.
HIV-1 Colorimetric RT-LAMP
WarmStart Colorimetric LAMP 2X Master Mix contains reverse transcriptase and thus
was used for the HIV-1 colorimetric RT-LAMP reaction. As stated in methods, all HIV-1 RTLAMP assays utilized 3 µL of template RNA (2.1x108 to 2.1x109 copies). Three primer sets
(targeting p24, protease, and integrase) were utilized to verify the modified LAMP technique
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because the non-conserved HIV-1 RNA genome is prone to mutation. The published protease
and p24 HIV-1 primer sets (see Table 2) had been optimized, with loop primers, at a 60oC
reaction temperature therefore HIV-1 RT-LAMP assays with these primers were conducted at
that temperature (unless otherwise stated) and with the use of loop primers. With these primer
sets, the modified FIP and BIP primers, substituting the poly-T-linkage with the 16-mer PNA
sequence, were successful in amplifying their respective target region in under 30 minutes
(Figure 27).

Figure 27. Colorimetric HIV-1 RT-LAMP with p24 and protease primer sets. The reactions
proceeded with 1) poly-T linker FIP/BIP, 2) PNA-linker FIP/BIP, 3) E. coli negative control, and
4) H2O negative control.

The designed integrase primer sets (3 sets total) were evaluated with real time turbidity to
determine the optimal designed primer set to proceed with the assessment of the modified 16mer linker sequence. Integrase primer set #3 (Table 2B) was chosen, based on RT-LAMP
turbidimetric results (Table 6), and was utilized in the colorimetric RT-LAMP reaction (Figure
28). These initial HIV-1 RT-LAMP results were encouraging, suggesting the efficacy for the
modified FIP and BIP primers to amplify their corresponding target using a viral model.
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Figure 28. Colorimetric RT-LAMP assay
with designed integrase primer set.

HIV-1 RT-LAMP with Turbidimetry
The HIV-1 modified primers targeting the integrase gene region of HIV-1 were evaluated
for their functionality in the RT-LAMP assay, using turbidimetry detection of LAMP
amplification. Two of the three designed primer sets (Primer set #1 and #3 [Table 2B]) were
successful in amplifying the target region. Run in triplicate, the integrase primer set #3 produced
a rapid positive result (33 minutes), while integrase primer set #1 was observed to be
significantly slower (Table 6).
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Table 6. Evaluation of designed HIV-1 Integrase Primer Sets.
Component

Threshold Time Tt (min:sec)

Average Tt with
Standard Deviation
(min:sec)

Df Value

Primer set #1

53:42

Primer set #1

52:48

Primer set #1

53:12

0.200

Primer set #2

_

0

Primer set #2

_

Primer set #2

_

0

Primer set #3

33:12

0.207

Primer set #3

32:48

Primer set #3

33:06

0.196
53:14 (+/-) 0.50

_

33:00 (+/-) 0.21

0.201

0

0.209
0.209

Similarly, to establish the efficacy of the designed integrase primer set (#3) with the
incorporation of the PNA-linker in the FIP and BIP, turbidity detection of HIV-1 RT-LAMP was
performed in triplicate. The results indicated rapid amplification (Tt) of the integrase primer set
(Figure 29) with both polyT-linker and PNA-linker primer sets.
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19:00 min
31:54 min
31:54 min

19:12 min

19:12 min

Absorbance

32:06 min

Figure 29. Positive Turbidity
RT-LAMP Reaction for the
HIV-1 integrase target.

Time (mins)

Sequence Verification of the Co-amplified PNA-Linker Sequence within HIV-1 Amplicon
Furthermore, this restriction digest of the PNA-linker was performed with the HIV-1
viral model. Additional viral negative controls (3 µL) were run with the RT-LAMP experiment;
with herpesvirus 1 and rhinovirus 17 input of 2.2x106 copies and 4.8x108, respectively. The
protease HIV-1 RT-LAMP product was digested with Msl I (Figure 30). Analysis of the
restriction digest indicated successful digestion of the amplicon containing the PNA-linker, and
unsuccessful digestion of the PolyT-linker amplicon. This was evident of the presence of the
PNA-linker (Msl I restriction site) within the HIV-1 protease amplicon. Similar to the nuc
amplicon Msl I digest, for the restriction digest for the protease amplicon (Figure 30), gel
electrophoresis resolved the difference in amplicon concatemer size of the PNA-linker versus the

46

PolyT-linker. This difference in banding pattern is due to the additional 12 base-pairs found
within the modified PNA-linker FIP/BIP.
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11

12 13

14

15

16

Figure 30. Verification of the co-amplification of the PNA-linker sequence within the HIV-1
protease RT-LAMP amplicon.
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The MB-LAMP results for HIV-1 protease indicated nonspecific fluorescence associated
with the PolyT-linker amplicon, similar to that observed with the S. aureus nuc LAMP product.
In a similar manner, the MB-RT-LAMP reaction was run at increased temperatures in an attempt
to reduce nonspecific molecular beacon fluorescence. Under the RT-LAMP conditions described
in the methods, the reaction efficiency (with loop primers) was significantly reduced beyond
63oC and primers for the HIV-1 (both p24 and protease) were not functional beyond 66oC. With
respect to these limits, at 66oC, nonspecific fluorescence associated with the PolyT-linker
amplicon was still observed (Figure 31).

PNA-linker p24 amplicon

Poly-T-linker p24 amplicon

Figure 31. MB-RT-LAMP at higher temperature continued nonspecific fluorescence.

The designed HIV-1 integrase primer set (#3, Table 2B) was also evaluated with MBLAMP. At 65oC, similar results were observed with this alternative HIV-1 primer set;
nonspecific fluorescence persisted (Figure 32). Following integrase RT-LAMP with
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turbidimetric detection, post-amplification detection of the RT-LAMP product with the
molecular beacon was attempted at 65oC, however no fluorescence was observed.

Poly-T-linker integrase
amplicon

PNA-linker integrase amplicon

Figure 32. MB-RT-LAMP detection of PNA-linker integrase amplicon along with nonspecific
fluorescence of polyT-linker integrase amplicon.

PNA/AuNP Colorimetric Detection of HIV-1 Amplicon
Colorimetric detection of the viral amplicon did not initially transfer over to the
PNA/AuNP detection system. A higher concentration of PNA was required to produce a negative
result for the Poly-T-linker HIV-1 amplicon (negative control that lacks the PNA target
sequence). This observation is likely attributed to the presence of reverse transcribed singlestranded cDNA. Li et al., describe the adsorption of ssDNA on gold nanoparticles, with exposed
nucleoside bases interacting with the AuNP surface, and protecting the AuNP from aggregation
(Li & Rothberg, 2004). Although this occurrence presented a problem for the PNA/AuNP
colorimetric detection of viral RT-LAMP products, a significant (5 fold) increase in PNA (1.5
µM) was able to achieve colorimetric results for HIV-1 protease (Figure 33) and HIV-1 p24
(Figure 34) amplicons. While the bacterial LAMP amplicon (lacking interfering ssDNA)
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produced blue/red colorimetric results within 60 seconds, it took 5-10 minutes for color
indication of positive/negative results with the HIV RT-LAMP product. This is likely a result of
PNA gradually displacing ssDNA, adsorbed on the surface of the AuNP, and inducing AuNP
aggregation.

Figure 34. PNA/AuNP detection of HIV-1 p24
RT-LAMP products.

Figure 33. PNA/AuNP detection of HIV-1
protease RT-LAMP products.
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DISCUSSION

This study was the first to attempt the development of a PNA/AuNP colorimetric
detection system for LAMP products. Further, to our knowledge, this was the first report of
modified LAMP primer linkages for the generation of a target-dependent, novel sequence for
probe detection. This novel LAMP technique, that co-amplifies an amplicon-tagged sequence,
complimentary to PNA probes, has the potential for universal detection of nucleic acid
biomarkers. These results support the feasibility for rapid, sequence-specific colorimetric
detection of both bacterial and viral agents with increased specificity over traditional LAMP
reactions, with the use of highly specific PNA probes.
This work demonstrates an operationally simple assay with high specificity that is a result
of sequence-specific detection. LAMP does not require temperature cycling steps required with
traditional amplification methods, nor does it demand nucleic acid isolation (Modak et al., 2016).
Therefore, crude cell lysate can be used from patient samples that include blood, saliva, urine,
mucus, or tissue specimen (Gubala, Harris, Ricco, Tan, & Williams, 2011). Additionally, this
LAMP with PNA/AuNP detection allows ease of use and interpretation of positive (red) and
negative (blue) results. Concurrently, this assay does not require complex equipment and may be
adapted to use by untrained individuals. This may have a potential impact on near-patient
diagnostics, resource limited clinical settings, in-home testing, or field testing (food/water) for
infectious disease.
Nucleic acid amplification offers many benefits over other diagnostic methods, although
sample processing presents a pronounced drawback for these techniques. LAMP technology
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overcomes this by not requiring a DNA/RNA extraction step. Additionally, numerous studies
have described superior sensitivity with LAMP, compared to conventional polymerase chain
reaction (PCR) methods (Lee et al., 2015; Lau et al., 2010).
Regarding PNA/AuNP colorimetric detection, these findings are comparable to previous
reports that PNA-DNA (Su & Kanjanawarut, 2009) and PNA-RNA complexes (Askaravi et al.,
2017) can sufficiently stabilize AuNP against aggregation. Additionally, our described detection
of LAMP amplicon involves immense excess of interfering, noncomplimentary DNA (DNAnc).
This reported PNA probe detection of the target sequence is consistent with previous studies that
identified PNA/AuNP-based detection of DNA, at room temperature, in the presence of high
concentrations of DNAnc (Kanjanawarut & Su, 2009).
Moreover, this work supports the potential for this diagnostic technology to be utilized
for POC testing. This LAMP technique coupled with the PNA/AuNP visual reporter system
generated sequence-specific colorimetric results in 30 to 60 minutes. It is important to consider
previously developed colorimetric detection methods of LAMP amplification; phenol red, a pH
indicator, has been shown to detect LAMP amplification via a change in pH (alkaline pH to
acidic pH) from the inherent production of protons that occurs during DNA synthesis (Tanner et
al., 2015). In comparison, hydroxy naphthol blue, a metal ion indicator, has demonstrated LAMP
detection, as Mg2+ is consumed (cofactor for Bst DNA polymerase) during amplification (Goto,
Honda, Ogura, Nomoto, & Hanaki, 2009). Eriochrome Black T, another metal ion chelator, has
also been employed in LAMP reaction detection (Oh et al., 2016). However, these detection
methods all involve indirect detection of LAMP products and thus cannon distinguish
nonspecific amplification from specific amplification. The sequence-specific detection of LAMP
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products described in this study provides an unprecedented approach to POC diagnostics with
the benefits of nucleic acid-based testing.
Employing this [16-mer linkage] modified FIP/BIP to tag amplicons with a novel
sequence, complimentary to PNA probes, did reduce the speed of the LAMP reaction. In the
absence of loop primers, with the S. aureus nuc LAMP assay, the reaction required up to an
additional 20 minutes to produce a positive result using the modified FIP/BIP. Similarly, with
loop primers, the HIV-1 LAMP assays required up to an extended 10 minutes to produce a
positive result with the modified FIP/BIP. The reduced efficiency of the LAMP reaction, using
primers with the modified 16-mer linker, is potentially attributed to the increase in distance
between the F1c and F2, which likely reduces the intermolecular interaction that is required for
the formation of the hairpin-loop, dumbbell-like, structure during the LAMP reaction. However,
despite this increased time required for the LAMP reaction, this methodology offers increased
specificity through use of the PNA/AuNP probe reporter system.
LAMP technology overcomes much of the limitations of NATs, such as requiring
equipment, technical training, procedure complexity, and long turn-around time. On the other
hand, the shortcomings of LAMP primary stem from the complexity of primer design. Also, the
series of concatemers composed of the target region produce ladder-like banding pattern on a
gel, rather than a single band of predicted size. The use of four primers further increases the
potential for primer interaction (primer dimerization) (Sahoo, Sethy, Mohapatra, & Panda, 2016).
However, using LAMP as a diagnostic screening technique, and with careful consideration to
primer design, these limitations can be alleviated.
In this investigation, amplification with the modified FIP and BIP, and incorporation of
the PNA-linker sequence into the LAMP products, was shown with pH-sensitive colorimetric
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detection (phenol red), turbidity detection, PNA/AuNP colorimetric detection, restriction
digestion, and with a molecular beacon. While the MB-LAMP method was capable of
identifying the PNA-target, novel sequence, non-specific fluorescence was associated with the
polyT-linker LAMP amplicon for all LAMP targeted regions in this study (nuc, p24, protease,
and integrase). These results were unexpected, although the MB-LAMP technique has only
recently been investigated; the single publication regarding MB-LAMP described atypical, linear
curves that occurred from negative controls. This group attributed this phenomenon to gradual
primer dimerization (Liu et al., 2017). Once more, the group did not include LAMP amplicon
products that were noncomplimentary to their molecular beacon. The process of isothermal
LAMP at lower temperatures (60-65oC) appears to allow nonspecific, partial hybridization, of
the molecular beacon and results in a fluorescent signal. Increasing the LAMP reaction
temperature enough to impede nonspecific molecular beacon hybridization was not feasible in
our case, because either 1) the molecular beacon melted off it’s target 16-mer sequence or 2)
higher temperatures inhibited the LAMP reaction.
Furthermore, the PNA/AuNP colorimetric detection of specifically [HIV-1] RT-LAMP
products will require continued improvement. The reverse transcription of RNA producing
single-stranded cDNA, has an apparent perverse effect on PNA/AuNP detection. As reported in
several previous studies, ssDNA competes with PNA for adsorption onto AuNP surfaces; while
PNA induces AuNP aggregation, ssDNA protects and stabilizes AuNP against aggregation (Li &
Rothberg, 2004). Despite this, it has been described that PNA has a higher affinity to AuNP than
the ssDNA counterpart (Su & Kanjanawarut, 2009). Therefore, we are continuing efforts in
improving and optimizing our PNA/AuNP detection system for RT-LAMP products.
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With the rapid and easily interpreted results previously described in this study, this
modified LAMP technique augmented with PNA/AuNP colorimetric detection has the potential
for in-home POC testing. Regarding this work, future research towards the miniaturization of
this amplification and visual reporter system may extend to in-home POC testing. Because the
LAMP reaction proceeds isothermally, a mobile or portable heat source may be used to produce
the necessary temperature conditions. LAMP primers can be stored freeze-dried (lyophilized) for
extended time periods, that may be applicable for a POC device (Gubala et al, 2011). As
previously mentioned, LAMP does not require a nucleic acid extraction step, making sample
preparation exceptionally simple for use by unskilled individuals. For example, this diagnostic
assay, used for HIV-1 screening, would only require a finger-stick blood sample from
patients/consumers. The WHO has expressed interested in improving HIV diagnostics; highly
sensitive and specific LAMP with PNA/AuNP detection may provide a superior POC method for
identifying early HIV infection. Herein, we have also demonstrated an easily interpreted and
extended-time-period visual output of results, with positive (red) and negative (blue) results
resolved on filter paper (Figure 24).
Overall, this study demonstrated the proof of principle for the sequence-specific
colorimetric detection of LAMP products, using a modified LAMP technique and PNA/AuNP
system, that can be used for the detection of both bacterial and viral pathogens. This work can
have a beneficial impact on the diagnostics of infectious disease, with the evidence supporting
the feasibility for highly specific, cost-effective, and rapid identification of infectious disease.
While this investigation models HIV-1 and Staphylococcus aureus, this described technology
may potentially be adapted for the detection of any microbial agent.
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